公共咨询

医疗器械登记 到 ANVISA

按号码、产品、持有公司或CNPJ搜索,数据是ANVISA在公开数据中发布的,每天都会到达这里。

记录的 DIASORIN LTDA取消

226 记录

产品持有公司班级有效性
LIAISON® Anti-HAV10339840542DIASORIN LTDAIII27/03/2033
Família LIAISON® HAV IgM10339840543DIASORIN LTDAIII17/07/2033
Família LIAISON® Biotrin Parvovírus B19 IgG Plus10339840547DIASORIN LTDAIII23/10/2033
Família LIAISON® Biotrin Parvovírus B19 IgM Plus10339840548DIASORIN LTDAIII23/10/2033
Família LIAISON® QuantiFERON®-TB Gold Plus10339840550DIASORIN LTDAIII05/02/2034
Família LIAISON® HSV-1/2 IgG10339840553DIASORIN LTDAIII06/05/2034
FAMÍLIA LIAISON® BRAHMS MR-proADM10339840554DIASORIN LTDAIII28/05/2034
Família LIAISON® HSV-1/2 IgM10339840557DIASORIN LTDAIII18/11/2034
Família LIAISON® VZV IgG HT10339840558DIASORIN LTDAIII13/01/2035
Família LIAISON® Rubella IgM10339840559DIASORIN LTDAIII10/02/2035
LIAISON® S. pneumoniae Ag10339840562DIASORIN LTDAIII31/03/2035
Família LIAISON® PSA II Gen10339840563DIASORIN LTDAIII05/05/2035
Familia LIAISON® Ferritina10339840564DIASORIN LTDAIII04/08/2035
Família LIAISON® TSH-R Ab10339840565DIASORIN LTDAIII15/12/2035
Família LIAISON® Quantiferon TB Gold Plus II10339840566DIASORIN LTDAIII02/02/2036
LIAISON VCA IgG10339840159DIASORIN LTDAIV22/12/2035
LIAISON EBV IgM10339840160DIASORIN LTDAIV02/03/2036
LIAISON CONTROL VCA IgG10339840248DIASORIN LTDAIV29/12/2035
LIAISON CONTROL EBV IgM10339840251DIASORIN LTDAIV02/03/2036
LIAISON Control EBNA IgG10339840307DIASORIN LTDAIV22/12/2035
LIAISON EBNA IgG10339840308DIASORIN LTDAIV22/12/2035
ICE* Syphilis10339840322DIASORIN LTDAIV01/08/2036
Murex HIV Ag/Ab Combination10339840327DIASORIN LTDAIV05/09/2036
MUREX HTLV I+II10339840328DIASORIN LTDAIV05/09/2036
Murex anti-HBc (Total)10339840422DIASORIN LTDAIV27/06/2036

来源: ANVISA 开放数据,健康产品档案. 基础带来注册的有效性,而不是记录情况:注册可能在期限之前被取消,而不会在这里出现。 咨询门户 ANVISA.

接下来的步骤

您的产品需要在巴西注册

HSC在 ANVISA 中进行医疗器械登记,从风险类框架到过程跟踪。

联系专家